ArticleCell communication and signaling : CCS2024

Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy.

Sujie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.